Stockreport

Eli Lilly: Exceptional 2025, But Rising Headwinds Loom In 2026 [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Lilly's international growth, especially for Monujaro, may slow as generics enter many markets post-semaglutide patent expiry in 2026. The oral GLP-1 race intensifies [Read more]